CV Sciences, Inc.
CVSI
$0.02
$0.008.33%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.99M | 3.20M | 3.31M | 3.26M | 3.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.99M | 3.20M | 3.31M | 3.26M | 3.62M |
| Cost of Revenue | 1.54M | 1.63M | 1.64M | 1.68M | 1.78M |
| Gross Profit | 1.45M | 1.56M | 1.67M | 1.58M | 1.84M |
| SG&A Expenses | 1.73M | 1.86M | 1.73M | 1.83M | 1.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 0.00 | -- | -- |
| Total Operating Expenses | 3.29M | 3.51M | 3.38M | 3.53M | 3.75M |
| Operating Income | -301.00K | -318.00K | -75.00K | -275.00K | -131.00K |
| Income Before Tax | -770.00K | -643.00K | -204.00K | -382.00K | -261.00K |
| Income Tax Expenses | 5.00K | -- | 2.00K | -- | -- |
| Earnings from Continuing Operations | -775.00K | -643.00K | -206.00K | -382.00K | -261.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -775.00K | -643.00K | -206.00K | -382.00K | -261.00K |
| EBIT | -301.00K | -318.00K | -75.00K | -275.00K | -131.00K |
| EBITDA | -279.00K | -295.00K | -54.00K | -244.00K | -73.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 205.09M | 186.92M | 184.26M | 184.26M | 184.26M |
| Average Diluted Shares Outstanding | 205.09M | 186.92M | 184.26M | 184.26M | 184.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |